Clinical Trial Update: A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the safety and effectiveness of acetaminophen extended-release (3900 mg/day) and ibuprofen (1200 mg/day) for pain associated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Sprain

Drugs mentioned

• Acetaminophen Extended-Release (acetaminophen)
• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Sprains and Strains, Pain | Phase 4 | Status: COMPLETED